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Activin has direct long-range signalling activity and can form a
concentration gradient by diffusion
N. McDowell, A.M. Zorn, D.J. Crease and J.B. Gurdon
Background: Activin has strong mesoderm-inducing properties in the early
Xenopus embryo, and has a long-range signalling activity that activates genes in
cells distant from a source in a concentration-dependent way. It has not yet
been established what mechanism of signal transmission accounts for this and
other examples of long-range signalling in vertebrates. Nor is it known whether
activin itself acts on distant cells or whether other kinds of molecules are used
for long-range signalling. Here we have used a well characterised model
system, involving animal caps of Xenopus blastulae treated with activin or
transforming growth factor β, to analyze some fundamental properties of long-
range signalling and of the formation of a morphogen gradient.
Results: We find that cells distant from the source of activin require functional
activin receptors to activate Xbrachyury, a result suggesting that activin itself
acts directly on distant cells and that other secondary signalling molecules are
not required. We also find that the signals can be transmitted across a tissue
that cannot respond to it; this argues against a relay process. We provide direct
evidence that labelled activin forms a concentration gradient emanating from its
source and extending to the distant cells that express Xbrachyury. Lastly, we
show that there is no inherent polarity in the responding tissue that influences
either the direction or rate of signalling.
Conclusions: The long-range signalling mechanism by which activin initiates
the transcription of genes in a concentration-dependent manner depends on a
process of rapid diffusion and the establishment of an activin gradient across
the tissue. It cannot be explained by a relay or wave propagation mechanism.
Activin itself is the signalling molecule to which distant cells respond.
Background
It is becoming clear that signalling between cells is an
important mechanism by which the diversity and spatial
arrangement of cells is generated in vertebrate develop-
ment. In Amphibia, where these processes have been
most fully investigated in the early stages of develop-
ment, a series of cell interactions takes place at intervals
of a few hours. These result in the induction and pattern-
ing of the mesoderm, neural tissue, and many other
tissues and organs. 
Signalling processes fall into two classes. Short-range
inductions involve direct contact between inducing and
responding cells, and are prevalent in embryos and organs
consisting of small cell numbers — for example, in the 4-
cell-stage nematode embryo [1]. In contrast to these cases,
the second class of signalling processes is long range and
includes examples where cells respond to signals originat-
ing in other cells with which they have no contact. The
signalling process must therefore be able to spread over
more than one cell diameter, and may do so over several
diameters in a few hours. Special interest attaches to these
examples of long-range effects where the signalling mole-
cule acts as a morphogen and is able to induce different
cell fates at different concentrations. Thus a single sig-
nalling event — the release of a morphogen — can gener-
ate a diversity of cell-types in a defined spatial
relationship to each other. The amphibian inductions
described above seem to fall into this category, about
which there has been a long history of theoretical discus-
sion and experimental contribution. These ideas are sum-
marised in a number of important reviews [2–7].
The experiments reported here concern activin as an
example of a morphogen. Activin, a member of the trans-
forming growth factor β (TGFβ) family of growth factors,
has potent mesoderm inducing activity in Xenopus [8],
and is present in Xenopus eggs [9] and early embryos
[10,11]. A new design of dominant-negative activin
receptor has recently been described [12]. This specifi-
cally inhibits activin, but does not affect Vg1 or any other
known mesoderm inducer effective in the Xenopus
embryo; since it disrupts mesoderm formation, it seems
that activin does indeed have an essential role in early
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Xenopus development. This result extends earlier work in
Xenopus [13] and in Medaka fish [14].
Activin signalling in Xenopus has the properties expected
of a morphogen. Using dissociated blastula cells, Green,
Smith and colleagues [15,16] demonstrated decisively
that different concentrations of activin elicit different
gene activations. We have described an experimental
system using activin-mRNA-containing cells, or activin
protein attached to beads, and intact blastula tissue, in
which activin appears to elicit different gene activations
at different concentrations [17]. We have used directional
conjugates of this kind to show that an increasing dose of
activin causes cells distant from the activin source to
express different genes [18,19]. There are two possible
mechanisms that can account for the long-range signalling
of a morphogen like activin. One possibility is that the
signal is transmitted across the tissue to distant cells
through a series of short-range interactions, in which one
cell signals to its immediate neighbour, causing it to emit
either the same or different molecules to its neighbours.
In this way, the signal is propagated from cell-to-cell by a
relay mechanism. Alternatively, long-range signalling
could occur by diffusion into the surrounding tissue of
either the initial signalling molecule itself, or via the acti-
vation and diffusion of a second long-range signal. Until
these two mechanisms are distinguished, we do not know
the identity of the molecule to which cells respond in
long-range signalling.
Evidence against a relay concept and in favour of a diffu-
sion model has been provided in Xenopus [20] and in
Drosophila [21,22]. It was found that a constitutively active
receptor, in the absence of ligand, cannot generate long-
range signalling. However, this approach does not rule out
the involvement of a second long-range signalling mole-
cule that is activated by the ligand-induced receptor but
not by the constitutive receptor. In contrast to the conclu-
sions from the constitutive receptor experiments, Reilly
and Melton [23] argue that, in Xenopus, patterning at a dis-
tance by TGFβ family members takes place by a process
of relay rather than by diffusion, with secondary signalling
molecules participating in the process. 
Here, we use tissue and bead recombination experi-
ments to provide positive evidence that the morphogen
behaviour of activin, as well as that of its related family
member TGFβ, is attributable to the diffusion of the
molecules themselves and does not depend on a relay
process. Furthermore, secondary signalling molecules
appear not to be involved, since cells distant from the
morphogen source respond to the original signalling mol-
ecules, activin or TGFβ. This conclusion therefore iden-
tifies activin as a molecule that forms a diffusion gradient
and whose concentration is directly assessed by the
responding cells.
Results
Activin activates distal Xbra directly
In our directional conjugate assay [17], in which two blas-
tula stage animal caps are sandwiched around activin-
coated beads, we showed by in situ hybridisation that
activin is able to induce, at a distance from the beads, a
band of Xbrachyury (Xbra) mRNA, an immediate early
response to mesoderm induction [24]. However, it is pos-
sible that activin is required only for the initiation, but not
for the continuation, of signalling in our system. For
example, it may be that activin travels only as far as the
first layer of responding cells, where it activates a second
signal and it is this which acts at long range to induce
Xbra. Such a process takes place in Drosophila wing and
leg discs, where Hedgehog acts at short range to induce a
long-range morphogen signal, Decapentaplegic (Dpp)
[25]. Likewise, in the limb bud, Sonic hedgehog appears
to act at short range to induce the long-range proliferative
agent bone morphogenetic protein 2 (BMP2) [25].
To distinguish a direct from indirect mechanism of sig-
nalling, we have asked whether activin is required in distal
cells as well as in cells near the source. The experimental
design is a modification of the directional conjugate assay
[17]. A three-layer conjugate was constructed in which an
intervening sheet of cells was sandwiched between an
animal cap and the activin beads (Figure 1a). This sheet is
an animal cap from which the outer impermeable cell
layer, which surrounds all Xenopus embryos, had been pre-
viously removed. We labelled this permeable ‘decoated’
sheet with the lineage label rhodamine lysinated dextran
(RLDx) to distinguish it from the upper animal cap, which
contains 2 ng of mRNA for the type 2 dominant-negative
activin receptor (ActRIIBdn) [13]. Hence, a band of Xbra
seen in the cells containing ActRIIBdn would suggest that
a second, non-TGFβ signal had replaced the original
activin signal in the decoated sheet of cells. Alternatively,
the absence of an Xbra band in the ActRIIBdn cells would
suggest that activin induces Xbra directly. The bottom
animal cap acts as a control to verify that the beads are of
sufficient strength to induce Xbra in distant cells.
The result can be seen in Figure 1b,c. Whereas an Xbra
band was induced in the bottom (control) cap and scattered
staining could also be seen in the decoated wild-type cells,
no Xbra band was present in the upper ActRIIBdn cells.
Similar results were obtained with beads of higher concen-
tration (data not shown). These experiments show that
functional activin receptors are required in the distal range
of signalling and that this process does not depend on a
second signalling molecule unrelated to activin. 
The dominant-negative receptor used above does not dis-
tinguish signalling by activin from that by other TGFβ
molecules. It is possible, therefore, that signalling by a
type of TGFβ other than activin is involved. A new type
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of dominant-negative receptor (ActRIIBexd) specifically
inhibits activin signalling when expressed at concentra-
tions of up to 1 ng of mRNA per animal cap [12]. In the
previous design of experiment, the concentration of
activin necessary to send the signal across the intervening
cell layer is too high to be completely blocked by only
1 ng of ActRIIBexd. That is, at such high concentrations of
activin, the cells expressing ActRIIBexd are still able to
partly respond (data not shown). We have therefore used
the following experimental design (Figure 1d). Beads with
a high concentration of activin were sandwiched between
two rhodamine-labelled animal caps and the conjugates
cultured for 2 hours; this is sufficient time for the signal to
spread into the caps. The conjugate was then dismantled
and the beads removed; one of the caps was placed next to
a wild-type, non-activin-treated blastula cap, while the
other was placed next to a cap injected with the
ActRIIBexd. Conjugates were then cultured for a further
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Figure 1
Activin does not induce Xbra via secondary
signalling. Two types of directional conjugate
were constructed (see text). (a) A decoated
animal cap of RLDx-labelled, wild-type cells
separates the ActRIIBdn cap (above) from the
activin beads. The lower wild-type cap
supporting the conjugate acts as a positive
control. (b) No Xbra band is seen in the upper
ActRIIBdn cells although scattered staining
can be seen at the distal edge of the
decoated cells and in the bottom control cap.
(c) RLDx labelling distinguishes the wild-type
decoated cells from the dominant-negative
cells. In none of the samples was an Xbra
band seen in the body of the ActRIIBdn
animal cap (total 47). (d) Experimental design
for ActRIIBexd: the activin signal passes from
the beads into the RLDx-labelled animal caps.
Following bead removal, one of the activin-
influenced caps is then placed next to either
an ActRIIBexd or a wild-type cap. (e,g) An
Xbra band has been induced in the cells of
the wild-type cap (12 out of 17 conjugates
with 5 beads of either 40 or 16 nM). (f,h) No
Xbra band, however, is present in the
ActRIIBexd cells (0 out of 18 conjugates). The
black lines demarcate the boundaries. 
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2 hours until the early gastrula (stage 10.5) when they
were fixed and stained for Xbra induction by in situ
hybridisation. The results are shown in Figure 1e–h.
While the activin-treated, rhodamine-labelled cap induced
an Xbra band in the non-activin-treated, wild-type cap, it
did not induce Xbra in the ActRIIBexd cells. We thus con-
clude that activin itself is acting as the long-range signal to
induce Xbra in cells distant from its source. 
TGFb2 protein can act directly as a long-range morphogen
by a mechanism of diffusion
The above result led us to ask whether the activin reaches
the distant cells by a mechanism of diffusion or relay. To
do this, we modified the design of the three-layer conju-
gate shown in Figure 1a so that, in this case, the middle
layer of decoated tissue cannot respond to the signal,
while the upper animal cap cells can respond. Initially, we
used the receptor ActRIIBdn to block response in the
decoated cells. However, we found that the type 2 domi-
nant-negative receptor sequestered the activin when over-
expressed in the decoated cells. This is because the
truncation does not eliminate the ligand-binding domain
of the type 2 monomer. Therefore, to obtain cells which
cannot respond and which will not sequester ligand, we
used the non-endogenous signalling molecule TGFβ2.
Although closely related to activin, neither TGFβ1 nor
TGFβ2 are present in Xenopus embryos and the cells do
not contain receptors for them. However, provided the
embryo has been previously injected with mRNA encod-
ing the type 2 TGFβ receptor (TGFβIIR), these ligands
can activate a wide range of mesodermal genes in an
induction similar to activin or Vg1 ([23,26] and our unpub-
lished data). The ability of either TGFβ1 or TGFβ2 to
have long-range signalling effects like activin, across cells
able to respond, has not however been reported.
To test this, we sandwiched TGFβ2-containing beads
between two animal caps. One cap had been injected with
mRNA for TGFβIIR and the other, unable to respond,
served as a control (Figure 2a). Conjugates were assayed
by in situ hybridisation for the induction of Xbra. Beads
loaded with a low concentration of TGFβ2 induced Xbra
in their immediate vicinity (Figure 2b), whereas high con-
centration beads induced an Xbra band at a distance in a
manner analogous to activin (Figure 2c). We conclude that
TGFβ2 protein can act as a morphogen and has long-range
signalling properties that are similar to activin. 
To test whether this long-range action is due to the TGFβ
itself or to the production of a secondary signal, we
repeated an assay similar to that described in Figure 1a for
activin. Wild-type cells, which cannot respond to TGFβ2,
were used in the upper layer in place of cells containing
dominant-negative receptor, while TGFβIIR-injected cells
provided the responding middle cell layer. Following in
situ hybridisation, an Xbra band was absent from the upper
non-responsive cell layer in all conjugates analysed (six
conjugates in two separate experiments; data not shown).
We therefore conclude that TGFβ2 signalling, like activin
signalling, is required over the whole of its range and that
secondary signalling molecules are not involved.
TGFβ2 therefore has the properties necessary of a long-
range signal and so can be used to distinguish diffusion
from relay. The experimental design, as explained earlier,
involved a three-layered conjugate in which the middle
layer cannot respond to the signal. In this case, as illus-
trated in Figure 2d, the middle decoated layer is wild-type
(rhodamine-labelled) and therefore is unable to respond to
the TGFβ ligand, while the upper layer contains
TGFβIIR and so can respond. Hence, if an Xbra response
is induced in these TGFβIIR cells, the TGFβ must have
passed across the intermediate, non-responsive cells by
diffusion through or around them. Alternatively, absence
of an Xbra band would suggest that a cell must receive and
respond to a signal in order to transmit it; this would
support a process of relay. 
The results are shown in Figure 2e,f. A band of Xbra was
observed in the upper cells containing TGFβIIR in all 26
conjugates analysed, while Xbra expression was never
seen in the intervening wild-type cells nor in the lower
control cells. Another immediate early gene, Xgoosecoid
(gsc) [27], was also assayed by in situ hybridisation and
found to be expressed in these upper cells (data not
shown). Since the cells of the middle layer are entirely
non-responsive to TGFβ2, signal passage across these
cells cannot have been by a relay mechanism. We there-
fore conclude that passage of the signalling molecule
across this middle layer took place by diffusion and not by
a relay process.
Our results appear to differ from those of Reilly and
Melton [23] who used TGFβ mRNA, injected into the 32-
cell-stage embryo, rather than protein bound to beads.
Since they did not observe an Xbra response in a clone of
distant TGFβRII cells, they concluded that TGFβ1
cannot diffuse across non-responding cells and that sig-
nalling must occur by a mechanism of relay. To investi-
gate this difference in the long-range signalling properties
of cells expressing TGFβ1 mRNA compared to mature
protein on beads, we asked whether an animal cap con-
taining TGFβ1 mRNA can induce Xbra at a distance in an
opposed cap containing TGFβII receptor and RLDx. We
found no induction of Xbra when either 500 pg or 1 ng of
TGFβ1 mRNA was injected. With 2 ng and 4 ng of TGFβ1
mRNA, Xbra induction was rarely seen, and even then
only in responding cells close to the signalling cells (6 con-
jugates out of 75; data not shown). Furthermore, the 4 ng
concentration also caused autoinduction in the signalling
cells. This result would therefore suggest that, unlike
beads coated with a mature form of the protein, cells
674 Current Biology, Vol 7 No 9
expressing TGFβ1 mRNA do not have long-range sig-
nalling properties (see Discussion).
Labelled activin enters animal cap tissue
Our experiments provide evidence that activin and TGFβ
exert their long-range effects via diffusion rather than by a
relay mechanism and we expect that these molecules
must diffuse from the beads into the responding tissue.
We therefore asked if activin can be found in animal caps
after activin-loaded beads have been removed. To this
end, we generated 35S-labelled activin protein from the
medium of Xenopus oocytes microinjected with synthetic
activin mRNA.
Each oocyte was injected with 50 ng of activin mRNA and
cultured in the presence of 35S-methionine for 3 days.
Naturally occurring activin is secreted from cells as a
complex between a mature processed dimer, which is
responsible for signalling, and a biologically inactive pro-
region [28–30]. Figure 3a shows reducing SDS-polyacry-
lamide gel electrophoresis (PAGE) analysis indicating that
the medium from activin-mRNA-injected oocytes was
highly enriched in activin protein. Mature processed
activin (14.5 kDa) and the larger processed pro-region
(approximately 40 kDa) together account for 75–85% of all
the labelled proteins secreted by activin-mRNA-injected
oocytes. In order to demonstrate that the activin in the
oocyte medium was biologically active and to estimate its
concentration, we compared our activin medium to puri-
fied activin in its ability to induce mesoderm in animal cap
tissue. Animal caps were treated with a dilution series of
either pure activin or oocyte medium and were assessed
by morphology and by RNase protection for the expres-
sion of the mesodermal genes Xbra and gsc (data not
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Figure 2
TGFβ2 can act as a morphogen and pass
across tissue composed of cells unable to
respond to it. (a–c) TGFβ2 can act as a
morphogen. (a) Two TGFβ2 beads were
sandwiched between an animal cap supplied
with TGFβIIR and a non-responsive (wild-
type), rhodamine-labelled animal cap. (b) With
weak beads (1 nM), the band in the receptor
injected cells is in the vicinity of the beads (5
out of 5 conjugates), while stronger beads
(20 nM) induce a band further away (5 out of
5 conjugates) (c). The black lines demarcate
the boundary between the receptor injected
and RLDx cells (not shown). (d) A modified
version of the three-layer conjugate, described
previously in Figure 1a. The middle decoated
layer (RLDx) is wild-type and hence cannot
respond to the TGFβ2 signal from the beads,
while cells of the upper animal cap can
respond since they contain TGFβIIR. (e) A
strong band of Xbra expression is induced in
the upper responding cap (26 conjugates out
of 26). (f) Rhodamine labelling demonstrates
that the wild-type decoated tissue forms a
continuous layer separating the receptor
injected cells from the beads. 
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shown). Typical activin concentrations in our oocyte
medium preparations were 100–400 ng/ml (5–20 nM) with
a specific activity of about 1–2 × 108 cpm/µg.
We used the labelled 35S-activin to look for radioactivity
diffusing from the beads into the tissue of the animal cap
conjugates. Incubation in 20 nM 35S-activin resulted in
1000–4000 cpm of 35S-activin (equivalent to 10–40 pg of
mature activin) per bead. Such beads were placed
between two animal caps and after approximately 4 hours,
a time during which we know that mesodermal genes are
normally activated in distant cells, the beads were
removed from the tissue. The material from 20 such con-
jugates was pooled and the labelled protein in the tissue
and that remaining on the beads was resolved on reducing
SDS-PAGE and visualised by fluorography. Figure 3b
shows that some 35S-activin had been released from beads
and was present in the animal cap tissue, as would be
expected if the long-range activin effect depends on dif-
fusion. About 5% of the activin loaded on to the beads
enters the tissue. This would be equivalent to an average
concentration of about 10–80 pM if the amount released
from the beads is spread evenly throughout the animal
cap tissue. 
We conclude from these experiments that activin leaves
the beads and enters the tissue. However, we have not
ruled out the possibility that the activin we detected in the
tissue was entirely bound to the cells immediately adjacent
to the beads, rather than having spread into the tissue. 
Direct visualisation of an activin concentration gradient
We have used the 35S-labelled activin in an attempt to
visualise directly a concentration gradient of activin in the
tissue of our animal cap conjugates. Beads loaded with
35S-activin from oocyte medium were placed between
two animal caps and cultured for approximately 4 hours,
during which time Xbra was activated in distant cells.
After fixation, conjugates were sectioned and the location
of the labelled activin protein was determined by autora-
diography. Figure 4a,c show dark field views of typical
autoradiographs resulting from these experiments. Over
12 conjugates from three separate experiments were
analysed. A white halo of autoradiographic silver grains
can be seen in the tissue around the bead. The halo of
silver grains appears to form a gradient, with the highest
density of silver grains in the tissue near the bead and
with a progressive dilution of grains in the tissue further
away from the bead. Figure 4b,d show bright field and
fluorescence views of the same conjugate. The conju-
gates containing activin beads exhibit a characteristic
morphology indicating the induction of mesodermal
tissue by the activin when compared to control conjugates
(vertical elongation in Figure 4a compared to the flat con-
jugate in Figure 4g). 
We have considered two ways in which our interpretation
of the results could be incorrect. One is that our 35S-activin
preparation might contain residual amounts of free 35S-
methionine and 35S-cysteine (typically 0–5% in our prepa-
ration), which could form a gradient of incorporation in the
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Figure 3
35S-labelled activin protein can spread from
beads into tissue. (a) Synthetic mRNA
encoding activin βB was micro-injected into
Xenopus oocytes that were cultured for
3 days in the presence of 35S-methionine
and 35S-cysteine. The labelled proteins in the
conditioned oocyte medium were resolved
by 15% SDS-PAGE in reducing conditions
and visualised by fluorography. Oocytes
injected with activin mRNA (+) contain both
the mature processed activin (∼14 kDa) as
well as a larger (∼40 kDa) secreted form with
a size consistent with that of unprocessed
activin. (b) Affigel beads were loaded with
labelled activin oocyte medium and
implanted into animal cap conjugates. After 4
h of culturing, the beads were recovered
from the tissue. The labelled proteins present
in the tissue or still bound to the beads were
resolved by 15% SDS-PAGE in reducing
conditions and visualised by fluorography.
Lane 1 shows protein bound to beads before
implantation. Lane 2 shows the proteins
remaining on the beads after removal from
tissue and lane 3 shows the activin protein
present in the tissue
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tissue if it were released progressively from the beads. In
order to control for any possible autoradiographic signal
due to this remaining free label, we prepared beads to
which was absorbed a greater amount of 35S-methionine
and 35S-cysteine than would have been present in the 35S-
activin beads. When free 35S-methionine and 35S-cysteine
containing beads were implanted into conjugates and cul-
tured for 4 hours, equivalent autoradiographs showed that
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Figure 4
Visualisation of an activin morphogen gradient
in tissue. Between 10 and 40 pg (1000–4000
cpm per bead; see Materials and methods) of
35S-labelled activin βB from oocyte medium
was loaded on to Affigel beads, the beads
were implanted in animal cap conjugates and
after 4 h of culturing conjugates were fixed,
sectioned and subjected to autoradiography.
(a,b) Low magnification of an activin bead in a
conjugate; (a) dark field view; (b) bright field
view; the white area in (a) is a dark field view
of autoradiographic grains. (c) A dark field
view of (a) at higher magnification. 
(d) Hoechst nuclear stain; the dotted circle
indicates the position of the bead. (e) Bright
field view of a section through a conjugate in
which the bead was dislodged before
autoradiography. (f) Bright field view of an
activin-bead containing conjugate, in which
the section shown has passed ∼25 µm above
the level of the edge of the bead. (g) Dark
field view of a conjugate with two beads
loaded with 35S-methionine and 35S-cysteine
only (no activin); the flat morphology shows no
response to activin. (h) High magnification of
a bright field autoradiograph shows a
concentration gradient. (i) NIH image software
was used to quantitate the average silver grain
density over sections of tissue. The results
were plotted relative to distance from the edge
of the bead position (referred to as tissue
edge). The graph depicts the concentration
gradient of activin across the tissue. 
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minimal grain density was not arranged in a gradient
(Figure 4g). This is probably because the free amino acids
diffuse away from the tissues during fixation and washing.
A second way in which our results could be misinterpreted
relates to the path length of 35S radioactivity. Could the
gradient of autoradiographic grains centred on a bead rep-
resent emissions from the molecules on the bead rather
than from molecules located under the grains in the
tissue? We exclude this interpretation for two reasons.
First, gaps between beads and nearby tissue (Figure 4a,c)
leave grain-free areas and therefore, even with a strong
source of radioactivity on the bead, the effective path
length of 35S emissions is less that 10 µm. Second, under
conditions where a bead has been removed before section-
ing (Figure 4e) or when the sections are at least 25 µm
above or below the bead (Figure 4f), we still see a clear
gradient of autoradiographic grains in the section. In these
cases, the bead is completely absent from the sections
during autoradiography and therefore it is impossible for
any silver grains in the tissue to have come from the
radioactivity of molecules on the beads. 
In the activin gradient that we see, autoradiographic grains
can be readily detected above background for at least
120 µm away from a bead, a distance of about 7 diameters
of cells in end to end contact (Figure 4d). With the strength
of beads used in these experiments, we typically see activa-
tion of the high-response mesodermal gene gsc within this
120 µm area where a gradient is clearly observed. However,
since the strength of beads used in these experiments
causes Xbra expression in cells at the outer periphery of the
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Figure 5
The polarity of responding tissue does not
affect direction or rate of signalling. (a,b) The
design of the experiment: the outer
impermeable surface coat was removed from
an animal cap and the tissue placed in either
an inverted or normal orientation. Cells
expressing Xbra RNA are the same distance
from an activin bead, whether the upper
decoated cap is in a normal orientation (c) or
180 degrees inverted (d). The lower animal
cap has a normal surface coat (pigmented)
and has been injected with rhodamine
lysinated dextran (RLDx). The black line (c,d)
demarcates the boundary between decoated
and rhodamine labelled cells (e, f). 
Decoated cap
Normal orientation
Decoated cap
Inverted orientation(a) (b)
(c) (d)
(e) (f)
conjugate, and since low concentrations of the activin gradi-
ent would not be seen by autoradiography, the actual
activin gradient is likely to extend to the edges of the con-
jugates. To obtain quantitation of the activin gradient, we
have examined the autoradiographs of conjugates of the
kind shown in Figure 4h using NIH imaging software. The
graph shown in Figure 4i is derived from preparations
where the bead is absent (as in Figure 4e) and illustrates
diagramatically an activin concentration gradient across the
tissue. These results provide positive evidence that activin
can diffuse through solid tissue and is able to reach cells
distant from an activin source.
Direction and rate of signal diffusion are not affected by
polarity of the responding tissue
An interesting possibility is that signal diffusion is influ-
enced by a polarisation of the responding tissue. Such a
polarisation, if due to a differential distribution of extra-
cellular matrix molecules, could aid the diffusion of
activin in one direction and thus help to establish the
form of the concentration gradient. We have therefore
asked whether the direction and rate of signal passage is
affected by the polarity of the animal cap along the
vegetal–animal axis — from the inside (blastocoel roof)
surface towards the outer surface.
The experimental design involved sandwiching two animal
caps around activin-coated beads. One of these caps had
previously been decoated. This enabled this decoated cap
to be inverted by 180° compared to its normal orientation
(Figure 5a,b). The distance of the Xbra band from the
beads could therefore be compared in the inverted cap and
in a decoated cap which had not been inverted. 
The results are shown in Figure 5c–f. In all cases where an
Xbra band was observed in the normally orientated cap, a
similar band was observed in the inverted cap (Figure 5c,d).
Furthermore, the rate of signalling, measured by distance of
the centre of the band from the signalling source, was
similar in the two types of conjugate. This was true when
beads of different activin doses were used and also when
the activin source was a cap injected with activin mRNA
(Table 1). Altogether, 23 conjugates with inverted caps and
22 conjugates with normally orientated caps were tested
and gave the results described. We therefore conclude that
the blastula animal tissue does not have a polarisation which
influences either the direction or rate of signal diffusion.
Discussion
Long-range signalling by activin is direct
A major conclusion from the work presented here is that
the long-range signalling process initiated by activin is
also mediated in the most distant responding cells by
activin itself. This therefore eliminates the involvement
of a non-activin secondary signalling molecule and identi-
fies activin as the molecule to which cells respond in a
concentration-dependent manner. The system we have
used for analysis is experimental and, although the role of
endogenous activin in mesoderm formation has yet to be
fully understood, it is clear that activin can behave as a
morphogen in Xenopus animal caps. The mechanism by
which it does so is likely to be helpful in understanding
other long-range signalling events in early development. 
The experimental system used here evades a number of
uncertainties that limit the interpretation of other examples
of long-range signalling. Most importantly, there is very
little cell division or cell movement [17], and the long-range
signalling effects cannot be explained by the division and
movement of cells after a short-range interaction (see [31]). 
Diffusion not relay
All of our results support a diffusion rather than a relay
mechanism of signalling. The fact that activin is required
for response by the distant cells does not itself preclude
the possibility that a relay process is involved, activin
being released, at an attenuated level, by each step in the
relay series. However, we have two kinds of evidence in
favour of diffusion. First, we show that activin-related
TGFβ2 can spread through tissue unable to respond to or
synthesise it. Hence the spread cannot be by relay.
Second, we show that radioactive activin, labelled by syn-
thesis and not by attachment of a tag, leaves the signalling
source and enters the responding tissue reaching cells not
in contact with the signal source. We conclude that, in the
model system used here, activin signalling takes place by
diffusion, not relay. It is therefore reasonable to suppose
that, in normal development, long-range signalling by
activin also occurs by a mechanism of diffusion. It is possi-
ble that, in normal development, a relay system may be
operative in addition to diffusion. 
Our evidence that both TGFβ and activin can diffuse is
consistent with our earlier experiments showing that
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Table 1
Rate of signalling is not influenced by the polarity of the
responding tissue.
Activin dose 5 nM beads 10 nM beads
Normal Inverted Normal Inverted
Number of samples 7 7 9 10
Minimum distance (µm) 100 100 140 160
Maximum distance (µm) 180 190 260 240
Table comparing the minimum and maximum distances (µm) between
the activin source (beads) and the centre of the Xbra band, for either a
‘normal’ or ‘inverted’ conjugate. Over the range of activin
concentrations used, the distances observed were similar for both
types of conjugate. Similar results were obtained when using activin-
mRNA-injected caps as the signalling source and placed next to either
normal or inverted animal caps and stained for Xbra expression.
activin can spread through re-aggregated endoderm (non-
responsive) tissue, as well as through re-aggregated cyclo-
heximide-treated cells, which cannot therefore synthesize
activin [17]. Furthermore, we believe that our results are
consistent with those of Reilly and Melton [23] who also
used non-endogenous TGFβ, but conclude that it signals
by a relay mechanism. It is likely that the apparent differ-
ence in results may be due to their use of cells expressing
TGFβ1 mRNA rather than beads loaded with TGFβ1
protein as the source of ligand. In our hands, while the
mature form of the protein has efficient long-range sig-
nalling properties across responsive (receptor injected)
cells, TGFβ mRNA injection does not induce Xbra in
distant responding cells. This may be contrasted with our
previous work [17] which showed that activin expressed
from mRNA-containing blastula cells does exhibit long-
range signalling properties, unlike TGFβ1 mRNA. The
lack of long-range signalling following mRNA injection of
TGFβ1 could be due to inefficient processing of a protein
that is a non-endogenous molecule. The ability of endoge-
nous TGFβs to exhibit long-range signalling may there-
fore be determined by how efficiently they are processed
and secreted from the cells in which they are synthesised.
Clear evidence for this was demonstrated by Jones et al.
[20]. They showed that a more efficiently processed form
of Xnr2 diffused from cells and exhibited a distance
effect, while the poorly processed wild-type form did not. 
Properties of the activin gradient 
There are many examples of long range signalling in
development that suggest the operation of a morphogen
gradient. However, there has so far been no direct demon-
stration of an extracellular gradient of signalling molecules
in the responding tissue. Thaller and Eichele [32]
obtained four decreasing values for retinoic acid in a chick
wing bud which had been exposed to retinoic acid beads.
It is not, however, clear that retinoic acid functions as a
morphogen in this system, at the nanomolar concentra-
tions observed. In many other cases, molecules with mor-
phogenetic effects — such as basic fibroblast growth
factor, TGFβ, BMP4, Dpp, and so on — have not been
detected outside the cells in which they are synthesized.
This is probably because they act as morphogens at extra-
ordinarily low concentrations (in the picomolar range) and
cannot be detected in a gradient by even the most sensi-
tive antibody procedures (our unpublished results) or
tagging methods [23]. The reason why we have been able
to see an activin gradient in our experiments is probably
due to the very high specific activity of relatively pure
activin synthesised and secreted by mRNA-injected
oocytes and loaded onto beads.
We estimate the average concentration of activin in
responding animal caps to be in the range of 10–80 pM,
based on our estimate of the specific activity of our
oocyte-synthesised 35S-labelled activin. If the average
concentration of activin in our animal cap experiments is
50 pM, the Xbra-inducing concentration, which is in the
most distant cells in these experiments, is likely to be
several fold lower, in reasonable agreement with the
20 pM concentration of activin found by Green et al. [16]
to induce Xbra in dissociated animal cap cells.
It is usual to discuss morphogen gradients in terms of a
source and a sink [33] and to assume that cells respond to an
equilibrium gradient. We suggest that response to a chang-
ing or ‘dynamic’ gradient may be more normal in early
development when new patterns of gene activation take
place at intervals over a period of a few hours or less. We
have shown that Xenopus blastula cells respond to increasing
activin concentrations by a ratchet-like process [18], that is
to the highest concentration that they experience within
their period of competence. It would therefore be unneces-
sary for an equilibrium gradient to be reached before cells
should respond to it. If an equilibrium gradient had to be
achieved within a few hours, it would be difficult to ensure
that cells would not respond to it prematurely. We therefore
think that cell response to a progressively increasing gradi-
ent, by a ratchet-like mechanism, would place less demands
on the precision of early developmental processes.
Materials and methods
Embryo injections
For the directional and multilayer conjugate experiments, embryos were
microinjected at the 2-cell stage in 1× MBS [34], 4% Ficoll, with either
2 ng ActRIIBdn mRNA, 1 ng ActRIIBexd mRNA, 4 ng TGFβII receptor
(TGFβIIR) mRNA [26], 500 pg, 1 ng, 2 ng or 4 ng TGFβI mRNA, or
30 ng rhodamine lysinated dextran (RLDx, Mr 104, Molecular Probes).
Embryological manipulations and bead preparation
Animal caps were cut at stage 8 and conjugates made as described in
text. Recombinant bovine activin βA (Genentech) and TGFβ2 (R and D
Systems) beads (Affi-gel blue, 100-200 mesh, Bio-Rad) at the concen-
trations cited in text and figure legends, were prepared according to
[17–19]. Animal cap constructs were cultured at 23°C in 1× MBS.
Where decoated caps were used, the outer impermeable cell layer was
removed from stage 8.5 embryos, in 1× MBS, by gently peeling it away
using fine forceps.
RNA expression constructs
Synthetic, capped mRNA was synthesized as described previously
[35,36] using a Mega-Script in vitro transcription kit (Ambion) and cap
analogue (New England Biolabs). Xenopus ActRIIBdn in pSP64T (a
gift from A. Hemmati-Brivanlou and D. Melton) was linearised with SfiI
and transcribed using T3 RNA polymerase. ActRIIBexd in pBluescrip-
tRN3P (a gift from S. Dyson) was linearised with SfiI and transcribed
with T3 RNA polymerase. The TGFb1 expression construct was
derived from pRKβ1E.C2S2 (a gift from R. Derynck) by cloning into
pBluescriptRN3P [36]. For capped sense mRNA it was linearized at
the SfiI site and transcribed using T3 RNA polymerase. TGFβIIR in
pSP64T (a gift from A. Bhushan) was linearized with EcoRI and tran-
scribed using SP6 RNA polymerase.
In situ hybridisation
In situ hybridizations, using either Xbra or Xgsc antisense probes, were
performed on sections as described by [36].
Autoradiography
Ilford K5 emulsion film was pipetted onto slides containing sectioned
material. After exposure for 3–6 weeks, slides were developed by stan-
dard procedures. 
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Stage VI oocytes were removed from adult Xenopus females and man-
ually defolliculated in 1× MBS. Oocytes were microinjected with 50 ng
synthetic capped Xenopus activin βB mRNA in 50 nl. 20 injected
oocytes were cultured for 3 days in 0.2 ml of 1× MBS; 0.1% BSA with
∼1 mCi/ml 35S-methionine and 35S-cysteine (Amersham) at 18°C. The
resulting oocyte medium was fractionated on a G-50 sepharose
column to remove free label from the preparation. After chromatogra-
phy, TCA precipitation and scintillation counting indicated that residual
free label accounted for no more than 0–5% of the total cpm in the
medium. Labelled proteins from the oocyte culture medium were
resolved on 15% reducing SDS-PAGE, and visualised by fluorography.
Activin proteins (mature plus processed pro-region) account for
75–85% of the total labelled proteins in the sample, as determined by
scintillation counting of activin bands excised from the gel. The concen-
tration of mature activin in the oocyte medium was 100–400 ng/ml
(5–20 nM), as determined by comparing the mesoderm inducing activ-
ity, in animal caps, of serial dilutions of the oocyte medium with those of
pure activin protein (Genentech). Mesoderm inducing activity of activin
was assayed by morphology of the animal caps and by an RNase pro-
tection assay for mesodermal genes. The specific activity of the 35S-
activin in the oocyte medium was 1–2 × 108 cpm/µg.
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